World's Best Scientists 2026 revealed!

D-Index & Metrics

Neuroscience

D-Index
119
Citations
58132
World Ranking
396
National Ranking
234

Daniel Weintraub publication distribution in Neuroscience in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Neuroscience in 2026. The highlighted bar marks where Daniel Weintraub sits on this spectrum.

38–47 publications: 18 scientists 48–57 publications: 79 scientists 58–67 publications: 193 scientists 68–77 publications: 323 scientists 78–87 publications: 406 scientists 88–97 publications: 452 scientists 98–107 publications: 539 scientists 108–117 publications: 505 scientists 118–127 publications: 522 scientists 128–137 publications: 469 scientists 138–147 publications: 456 scientists 148–157 publications: 459 scientists 158–167 publications: 397 scientists 168–177 publications: 383 scientists 178–187 publications: 350 scientists 188–197 publications: 302 scientists 198–207 publications: 306 scientists 208–217 publications: 262 scientists 218–227 publications: 242 scientists 228–237 publications: 220 scientists 238–247 publications: 203 scientists 248–257 publications: 174 scientists 258–267 publications: 176 scientists 268–277 publications: 175 scientists 278–287 publications: 125 scientists 288–297 publications: 116 scientists 298–307 publications: 127 scientists 308–317 publications: 128 scientists 318–327 publications: 99 scientists 328–337 publications: 89 scientists 338–347 publications: 78 scientists 348–357 publications: 96 scientists 358–367 publications: 66 scientists 368–377 publications: 59 scientists 378–387 publications: 65 scientists 388–397 publications: 54 scientists 398–407 publications: 48 scientists 408–417 publications: 49 scientists 418–427 publications: 34 scientists 428–437 publications: 31 scientists 438–447 publications: 30 scientists 448–457 publications: 31 scientists 458–467 publications: 36 scientists 468–477 publications: 40 scientists 478–487 publications: 35 scientists 488–497 publications: 30 scientists 498–507 publications: 23 scientists 508–517 publications: 26 scientists 518–527 publications: 20 scientists 528–537 publications: 23 scientists 538–547 publications: 20 scientists 548–557 publications: 20 scientists 558–567 publications: 17 scientists 568–577 publications: 14 scientists 578–587 publications: 20 scientists 588–597 publications: 20 scientists 598–607 publications: 19 scientists 608–617 publications: 18 scientists 618–627 publications: 17 scientists 628–637 publications: 11 scientists 638–647 publications: 11 scientists 648–657 publications: 11 scientists 658–667 publications: 8 scientists 668–677 publications: 7 scientists 678–687 publications: 11 scientists 688–697 publications: 10 scientists 698–707 publications: 4 scientists 708–717 publications: 6 scientists 718–727 publications: 5 scientists 728–737 publications: 5 scientists 738–747 publications: 9 scientists 748–757 publications: 9 scientists 758–767 publications: 3 scientists 768–777 publications: 7 scientists 778–787 publications: 7 scientists 788–797 publications: 6 scientists 798–807 publications: 2 scientists 808–817 publications: 2 scientists 818–827 publications: 7 scientists 828–837 publications: 0 scientists 838–847 publications: 9 scientists 848–857 publications: 3 scientists 858–867 publications: 1 scientists 868–877 publications: 3 scientists 878–886 publications: 6 scientists 887+ publications: 100 scientists
38 publications 887+

This scientist: 500 publications — 95th percentile

95% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 887 publications or more.

Daniel Weintraub D-index placement in Neuroscience in 2026

The chart shows the D-index (discipline H-index) distribution of Neuroscience scientists ranked by Research.com in 2026. The highlighted bar marks where Daniel Weintraub sits on this spectrum.

30–31 D-Index: 42 scientists 32–33 D-Index: 172 scientists 34–35 D-Index: 296 scientists 36–37 D-Index: 435 scientists 38–39 D-Index: 459 scientists 40–41 D-Index: 456 scientists 42–43 D-Index: 467 scientists 44–45 D-Index: 478 scientists 46–47 D-Index: 512 scientists 48–49 D-Index: 435 scientists 50–51 D-Index: 425 scientists 52–53 D-Index: 418 scientists 54–55 D-Index: 392 scientists 56–57 D-Index: 357 scientists 58–59 D-Index: 334 scientists 60–61 D-Index: 328 scientists 62–63 D-Index: 260 scientists 64–65 D-Index: 278 scientists 66–67 D-Index: 239 scientists 68–69 D-Index: 250 scientists 70–71 D-Index: 210 scientists 72–73 D-Index: 200 scientists 74–75 D-Index: 189 scientists 76–77 D-Index: 170 scientists 78–79 D-Index: 146 scientists 80–81 D-Index: 113 scientists 82–83 D-Index: 126 scientists 84–85 D-Index: 100 scientists 86–87 D-Index: 84 scientists 88–89 D-Index: 99 scientists 90–91 D-Index: 84 scientists 92–93 D-Index: 85 scientists 94–95 D-Index: 72 scientists 96–97 D-Index: 76 scientists 98–99 D-Index: 45 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 43 scientists 104–105 D-Index: 32 scientists 106–107 D-Index: 45 scientists 108–109 D-Index: 50 scientists 110–111 D-Index: 32 scientists 112–113 D-Index: 39 scientists 114–115 D-Index: 32 scientists 116–117 D-Index: 29 scientists 118–119 D-Index: 27 scientists 120–121 D-Index: 19 scientists 122–123 D-Index: 23 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 16 scientists 128–129 D-Index: 24 scientists 130–131 D-Index: 13 scientists 132–133 D-Index: 21 scientists 134–135 D-Index: 17 scientists 136–137 D-Index: 14 scientists 138–139 D-Index: 15 scientists 140–141 D-Index: 10 scientists 142–143 D-Index: 10 scientists 144–145 D-Index: 13 scientists 146–147 D-Index: 9 scientists 148–149 D-Index: 8 scientists 150–151 D-Index: 6 scientists 152–153 D-Index: 6 scientists 154–155 D-Index: 7 scientists 156–157 D-Index: 7 scientists 158–159 D-Index: 10 scientists 160–161 D-Index: 4 scientists 162 D-Index: 8 scientists 163+ D-Index: 100 scientists
30 D-Index 163+

This scientist: 119 D-Index — 96th percentile

96% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 163 D-Index or more.

Overview

Daniel Weintraub is affiliated with the University of Pennsylvania in the United States and is primarily engaged in the field of medicine, with a particular focus on neurology.

They have contributed extensively to research on Parkinson's disease and related neurological disorders. Their main research topics include:

  • Parkinson's Disease Mechanisms and Treatments
  • Neurological Disorders and Treatments
  • Dementia and Cognitive Impairment Research
  • Alzheimer's Disease Research and Treatments
  • Autism Spectrum Disorder Research
  • Botulinum Toxin and Related Neurological Disorders
  • Attention Deficit Hyperactivity Disorder

Their work spans several subfields, notably:

  • Neurology
  • Psychiatry and Mental Health
  • Cognitive Neuroscience
  • Physiology
  • Clinical Psychology

Key recent publications by Daniel Weintraub include:

  • "Parkinson disease-associated cognitive impairment," 2021, Nature Reviews Disease Primers
  • "Assessment of heterogeneity among participants in the Parkinson's Progression Markers Initiative cohort using α-synuclein seed amplification: a cross-sectional study," 2023, The Lancet Neurology
  • "A biological definition of neuronal α-synuclein disease: towards an integrated staging system for research," 2024, The Lancet Neurology
  • "Diagnosis and management of dementia with Lewy bodies: Fourth consensus report of the DLB Consortium," 2020, Newcastle University ePrints (Newcastle University)
  • "Levodopa Dose Equivalency in Parkinson's Disease: Updated Systematic Review and Proposals," 2023, Movement Disorders

Their collaboration network includes frequent coauthors such as Alberto J. Espay, Keith A. Josephs, Federico Rodríguez-Porcel, Rhonna Shatz, and Andrew Siderowf.

Daniel Weintraub has published extensively in several journals, with most frequent publications appearing in:

  • Movement Disorders
  • bioRxiv (Cold Spring Harbor Laboratory)
  • Neurology
  • Parkinsonism & Related Disorders
  • Movement Disorders Clinical Practice

In addition to research articles, Weintraub has contributed to academic books. One notable publication is titled Common Pitfalls in Cognitive and Behavioral Neurology, published by Cambridge University Press in 2020.

Best Publications

  • Diagnosis and management of dementia with Lewy bodies Fourth consensus report of the DLB Consortium

    Ian G. McKeith;Bradley F. Boeve;Dennis W. DIckson;Glenda Halliday

  • Diagnostic Criteria for Mild Cognitive Impairment in Parkinson’s Disease: Movement Disorder Society Task Force Guidelines

    Irene Litvan;Jennifer G. Goldman;Alexander I. Tröster;Ben A. Schmand

  • Impulse Control Disorders in Parkinson Disease: A Cross-Sectional Study of 3090 Patients

    Daniel Weintraub;Juergen Koester;Marc N. Potenza;Andrew D. Siderowf

  • Validity of the MoCA and MMSE in the detection of MCI and dementia in Parkinson disease

    S. Hoops;S. Nazem;A. D. Siderowf;J. E. Duda

  • Effectiveness of atypical antipsychotic drugs in patients with Alzheimer's disease.

    Lon S. Schneider;Pierre N. Tariot;Karen S. Dagerman;Sonia M. Davis

  • Parkinson disease-associated cognitive impairment.

    Dag Aarsland;Dag Aarsland;Lucia Batzu;Glenda M Halliday;Gert J Geurtsen

  • The Movement Disorder Society Evidence-Based Medicine Review Update: Treatments for the non-motor symptoms of Parkinson's disease

    Klaus Seppi;Daniel Weintraub;Miguel Coelho;Santiago Perez-Lloret

  • Cognitive decline in Parkinson disease

    Dag Aarsland;Byron Creese;Byron Creese;Marios Politis;K. Ray Chaudhuri

  • Mild cognitive impairment in Parkinson disease: a multicenter pooled analysis.

    D. Aarsland;K. Bronnick;C. Williams-Gray;D. Weintraub

  • MDS Task Force on Mild Cognitive Impairment in Parkinson’s disease: Critical Review of PD-MCI

    Irene Litvan;Dag Aarsland;Charles H. Adler;Jennifer G. Goldman

  • Past, present, and future of Parkinson's disease: A special essay on the 200th Anniversary of the Shaking Palsy

    J.A. Obeso;M. Stamelou;M. Stamelou;C.G. Goetz;W. Poewe

  • Association of dopamine agonist use with impulse control disorders in Parkinson disease.

    Daniel Weintraub;Andrew D. Siderowf;Marc N. Potenza;Joseph Goveas

  • Depression Rating Scales in Parkinson’s Disease: Critique and Recommendations

    Anette Schrag;Paolo Barone;Richard G. Brown;Albert F.G. Leentjens

  • Neurodegenerative disease concomitant proteinopathies are prevalent, age-related and APOE4-associated

    John L Robinson;Edward B Lee;Sharon X Xie;Lior Rennert

  • Assessment of heterogeneity among participants in the Parkinson's Progression Markers Initiative cohort using α-synuclein seed amplification: a cross-sectional study

    Unknown

  • Pramipexole for the treatment of depressive symptoms in patients with Parkinson's disease: a randomised, double-blind, placebo-controlled trial

    Paolo Barone;Werner Poewe;Stefan Albrecht;Catherine Debieuvre

  • The Parkinson's progression markers initiative (PPMI): establishing a PD biomarker cohort

    Kenneth Marek;Sohini Chowdhury;Andrew Siderowf;Shirley Lasch

  • Effect of Citalopram on Agitation in Alzheimer Disease: The CitAD Randomized Clinical Trial

    Anton P. Porsteinsson;Lea T. Drye;Bruce G. Pollock;D. P. Devanand

  • Validation of the Questionnaire for Impulsive-Compulsive Disorders in Parkinson's Disease

    Daniel Weintraub;Staci Hoops;Judy A. Shea;Judy A. Shea;Kelly E. Lyons

  • Neuropathological and Genetic Correlates of Survival and Dementia Onset in Synucleinopathies: A Retrospective Analysis

    David J Irwin;Murray Grossman;Daniel Weintraub;Daniel Weintraub;Howard I Hurtig

  • Impulse control disorders in parkinson disease: A multicenter case–control study

    Valerie Voon;Mandy Sohr;Anthony E. Lang;Marc N. Potenza

  • Research Articles Depression Rating Scales in Parkinson's Disease: Critique and Recommendations

    Anette Schrag;Paolo Barone;Richard G. Brown;William M. McDonald

  • EffectofCitalopramonAgitationinAlzheimerDisease The CitAD Randomized Clinical Trial

    Anton P. Porsteinsson;Lea T. Drye;Bruce G. Pollock;D. P. Devanand

Frequent Co-Authors

John E. Duda
John E. Duda University of Pennsylvania
Andrew Siderowf
Andrew Siderowf University of Pennsylvania
Alberto J. Espay
Alberto J. Espay University of Cincinnati
John Q. Trojanowski
John Q. Trojanowski University of Pennsylvania
Matthew B. Stern
Matthew B. Stern University of Pennsylvania
Keith A. Josephs
Keith A. Josephs Mayo Clinic
Dag Aarsland
Dag Aarsland King's College London
Sharon X. Xie
Sharon X. Xie University of Pennsylvania
Howard I. Hurtig
Howard I. Hurtig University of Pennsylvania
Lon S. Schneider
Lon S. Schneider University of Southern California

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For students interested in Neuroscience, pursuing online degrees can offer flexibility and faster program completion. Many universities now offer accelerated bachelor's degree online programs, enabling you to graduate quickly and enter the workforce or pursue further education sooner.

Neuroscience is a multidisciplinary field linked to numerous in-demand and profitable careers. Students often wonder about the highest paying majors or how neuroscience ranks among the most lucrative majors. While specific salaries vary, roles such as research scientists, pharmacologists, and neuropsychologists are known for strong earning potential.

Affordability is a key concern for many. Fortunately, there are cheapest online colleges that accept fafsa in usa, which can help students reduce financial barriers while studying neuroscience or related fields. Choosing the right program means balancing career goals, salary potential, and cost to make the most of your educational investment.

Best Scientists Citing Daniel Weintraub

Trending Scientists

Recently Published Articles